adenocarcinoma
Immunotherapy Response Features Identified in Pancreatic Cancer Microenvironment
Researchers compared tumor microenvironment features in pancreatic ductal adenocarcinoma cases receiving an allogeneic vaccine with or without anti-PD-1 treatment.
NCI researchers performed a multi-platform study to elucidate the factors that can contribute to a patient's better-than-expected response to a drug.